As of October 2024, Oryzon Genomics has a market cap of $125.54M. This makes Oryzon Genomics the world's 19998th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $126.75M | 0.11% |
2023 | $126.61M | -23.87% |
2022 | $166.32M | -8.15% |
2021 | $181.07M | -22.86% |
2020 | $234.72M | 25.90% |
2019 | $186.43M | 28.41% |
2018 | $145.19M | -17.21% |
2017 | $175.37M | -39.87% |
2016 | $291.66M | 20.81% |
2015 | $241.43M | - |